Analyst Expectations for Ultragenyx Pharmaceutical's Future

Loading...
Loading...

Ultragenyx Pharmaceutical RARE has observed the following analyst ratings within the last quarter:

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 2 4 1 0 0
Last 30D 1 0 0 0 0
1M Ago 1 0 0 0 0
2M Ago 0 0 0 0 0
3M Ago 0 4 1 0 0

These 7 analysts have an average price target of $83.0 versus the current price of Ultragenyx Pharmaceutical at $43.55, implying upside.

Below is a summary of how these 7 analysts rated Ultragenyx Pharmaceutical over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and the greater the number of bearish ratings, the more negative analysts are on the stock

This current average represents a 10.94% decrease from the previous average price target of $93.20.

Stay up to date on Ultragenyx Pharmaceutical analyst ratings.

How Are Analyst Ratings Determined?

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...